Pioneer in clinical trial artificial intelligence tech company- UK’s Sensyne Health has announced to kick start a new research project deal with Swiss giant Roche. This will further also help support clinical trial planning. Sensyne deals with anonymized patient information to help structure clinical studies and fuel drug discovery research. This is a second deal within half a year after Sensyne collaborated with Germany’s Bayer to obtain access to patient data from the U.K. National Health Service, and by means of AI, it obtained further insights. Bayer reportedly paid £5 million ($6.1 million) for the first two years of collaboration, which also includes options of further expansion.

Source: News 24 December 30, 2019 12:11 UTC